Skip to main content

Peer Review reports

From: Treatment of recurrent malignant gliomas with fotemustine monotherapy: impact of dose and correlation with MGMT promoter methylation

Original Submission
28 Aug 2008 Submitted Original manuscript
23 Sep 2008 Reviewed Reviewer Report - CARMEN BALAÑA
24 Sep 2008 Reviewed Reviewer Report - Antonio Silvani
14 Oct 2008 Reviewed Reviewer Report - Bernd Kaina
8 Nov 2008 Author responded Author comments - Alessandra Fabi
Resubmission - Version 2
8 Nov 2008 Submitted Manuscript version 2
17 Dec 2008 Reviewed Reviewer Report - CARMEN BALAÑA
Resubmission - Version 3
Submitted Manuscript version 3
12 Feb 2009 Author responded Author comments - Alessandra Fabi
Resubmission - Version 4
12 Feb 2009 Submitted Manuscript version 4
7 Mar 2009 Author responded Author comments - Alessandra Fabi
Resubmission - Version 5
7 Mar 2009 Submitted Manuscript version 5
30 Mar 2009 Author responded Author comments - Alessandra Fabi
Resubmission - Version 6
30 Mar 2009 Submitted Manuscript version 6
Publishing
31 Mar 2009 Editorially accepted
31 Mar 2009 Article published 10.1186/1471-2407-9-101

You can find further information about peer review here.

Back to article page